Journalist Amy Robach reflects on her journey—and how women like Rebecca are reclaiming their lives after diagnosis.

TARGETED treatments for prostate cancer were a central theme at the European Society for Medical Oncology (ESMO) Congress ...

Incidence of venous thromboembolism remains 'substantial' despite expert guidelines and newer risk prediction scores ...

Recursion (Nasdaq: RXRX), a clinical-stage TechBio company decoding biology to radically improve lives, today announced positive Phase 1b/2 data from the ongoing TUPELO trial of REC-4881, an ...

Our understanding of human placenta formation just deepened with the discovery of a gene essential to early embryonic ...

This study systematically screened over 1,000 agricultural and industrial chemicals and found that many can inhibit human gut ...

Get in the holiday spirit with this collection of Christmas movies streaming now on Hulu, featuring family fun, Santa Claus, ...

Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...

The report surfaces a striking contradiction at the center of modern finance: although 66% of CFOs expect significant AI ROI within two years, only 14% report meaningful value today. Based on insights ...

With a new edition of a long-running awareness campaign, Genentech is drawing attention to the talents and passions that are ...

November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies ...

The total number of federal employees impacted by the DEI rollback is unknown, but the lawsuit suggests it could be ...